Lee M. Techner
Chief Tech/Sci/R&D Officer at Adolor Corp.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Donald E. Nickelson | M | 91 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 21 years |
Claude H. Nash | M | - |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 24 years |
Kenneth J. Martin | M | 70 | 11 years | |
Lizanne Wentz | F | - |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | - |
David P. Geoghegan | M | - |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | 20 years |
Kevin Darryl White | M | - |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David McGirr | M | 69 | 12 years | |
Thomas DesRosier | M | 69 | 2 years | |
J. Singleton | M | 71 | 11 years | |
Patrick Volkert Vink | M | 60 | 3 years | |
Michael B. Wood | M | 78 | 9 years | |
Tamara Joseph | F | 61 | 4 years | |
Alison Lawton | F | 62 | 2 years | |
Jane Ellen Henney | M | 76 | 2 years | |
Martin Rosenberg | M | 78 | 9 years | |
Thomas J. Ouellette | M | - | 1 years | |
Thomas E. Rollins | M | - | 1 years | |
Santosh Vetticaden | M | 65 | 4 years | |
Joseph Farmer | M | 52 | 3 years | |
Lorianne K. Masuoka | M | 62 | 2 years | |
Carrie Bourdow | F | 61 | 2 years | |
Timothy Keutzer | M | 56 | 1 years | |
Ben Harshbarger | M | 55 | 4 years | |
Matthew P. Kowalsky | M | 52 | 2 years | |
Orlando Oliveira | M | - | 1 years | |
Larry G. Edwards | M | 52 | 1 years | |
Francesco Maria Lavino | M | 51 | 2 years | |
William Steinkrauss | M | 39 | 3 years | |
Jerald Korn | M | 45 | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 29 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Lee M. Techner
- Personal Network